High-risk human papillomavirus (HPV) infection is involved in a substantial subset of penile squamous cell cancers, but HPV infection is common and most infections clear without causing cancer. HPV-positive and HPV-independent penile cancers represent different biological pathways. Persistent infection with oncogenic types—especially HPV 16—is the important concern, often alongside smoking or immune suppression. Vaccination reduces the risk of HPV-related disease and is most effective before exposure, although eligibility for catch-up vaccination depends on age and local recommendations.

How HPV can contribute to penile cancer

High-risk HPV can integrate into cells and disrupt normal tumour-suppressor pathways. Over years, persistent infection may contribute to precancerous penile intraepithelial neoplasia and eventually invasive cancer. This is not an immediate progression from a new HPV exposure.

HPV does not equal cancer

Most sexually active adults are exposed to HPV at some point. There is usually no routine HPV screening test for asymptomatic men comparable with cervical screening. A visible lesion is assessed on its own clinical merits and biopsied when suspicious.

Is there a routine HPV screening test for men?

For asymptomatic men there is no routine penile HPV screening programme comparable with cervical screening. HPV swabs or blood tests are therefore not used to decide whether a man has penile cancer. A persistent penile lesion is assessed by examination and, when suspicious, biopsy. In practice, what the lesion looks and feels like—and whether it persists despite appropriate treatment—matters more than trying to prove past HPV exposure.

Vaccination

HPV vaccines protect against important oncogenic and wart-causing types. They are preventive rather than treatments for an existing penile cancer. Vaccination also contributes to prevention of other HPV-related cancers and genital warts.

Can treatment “clear” HPV?

There is no medicine that simply eradicates HPV from the body. Most infections are controlled naturally by the immune system. Treatment is directed at visible warts, precancerous change or cancer when present. Smoking cessation and management of immune suppression are important because persistent infection is more likely when immune clearance is impaired. Vaccination prevents infection with important HPV types but does not treat an established penile tumour.

Smoking and immune status

Smoking increases the risk of penile squamous cell carcinoma and can impair immune clearance of HPV. Immunosuppressed patients may have more persistent HPV disease and need a lower threshold for evaluation of persistent lesions.

What if pathology says p16 positive?

Pathologists may use p16 immunohistochemistry and/or HPV testing to classify HPV-associated tumours. This helps biological classification but does not replace standard tumour staging, grade and lymph-node assessment when determining treatment.

HPV-related and HPV-independent cancers are not identical

A proportion of penile squamous-cell cancers are related to high-risk HPV, particularly HPV16, while others arise through HPV-independent pathways often associated with chronic inflammatory disease. HPV status can have pathological and prognostic relevance, but it does not replace conventional staging and nodal assessment.

HPV status does not replace examination or biopsy

Penile squamous cancers include HPV-associated and HPV-independent pathways. HPV exposure is common and usually does not lead to cancer, so a positive HPV history does not diagnose malignancy. Conversely, a penile cancer can occur without HPV. Vaccination, smoking cessation and treatment of persistent premalignant lesions can reduce risk, but any persistent ulcer, growth or bleeding lesion still needs direct assessment regardless of presumed HPV status.

When to seek earlier medical review

A positive HPV history alone does not require emergency review. Persistent penile warts/plaques that ulcerate, bleed, harden, enlarge or fail appropriate treatment should be examined and biopsied when indicated.

What to bring to your consultation

• Any biopsy/HPE report of penile lesion
• HPV vaccination/history if known
• Smoking history and prior wart/lesion treatments
• Staging scans if cancer is already diagnosed

Questions to ask your doctor

• Does HPV status change my treatment or mainly explain tumour biology?
• Should a visible lesion be biopsied regardless of HPV testing?
• Would HPV vaccination still be useful for prevention in my family?

FAQs

Related reading

• Penile Cancer: Symptoms and Treatment
• Non-Healing Ulcer on Penis
• Phimosis and Penile Cancer Risk
• Groin Lymph Nodes in Penile Cancer: Why They Matter?
• Urologist in Latur

References

• European Association of Urology (EAU). Penile Cancer Guidelines. Diagnostic Evaluation and Staging https://uroweb.org/guidelines/penile-cancer/chapter/diagnostic-evaluation-and-staging
• European Association of Urology (EAU). Penile Cancer Guidelines. Disease Management https://uroweb.org/guidelines/penile-cancer/chapter/disease-management
• National Cancer Institute. Penile Cancer Treatment (PDQ) https://www.cancer.gov/types/penile/hp/penile-treatment-pdq